Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Etanercept, sold under the brand name Enbrel among others, is a biologic medical product that is used to treat autoimmune diseases by interfering with tumor necrosis factor (TNF), a soluble inflammatory cytokine, by acting as a TNF inhibitor. It has US Food and Drug Administration (FDA) approval to treat rheumatoid arthritis, juvenile idiopathic…
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Etanercept. 1 topic appears in more than one source area, which can help identify connections that are less obvious in a linear reading.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Etanercept shows recurring relationship patterns in the source. For example, Etanercept → Another, Beutler, Brian Seed, Bruce, Dallas, Immmunex, Immunex, Massachusetts General Hospital, November, September, Texas Southwestern Medical Center, The, United States, University Another extracted example is Etanercept → Ankylosing, April, AS, In, January, July, May, Moderate, November, Psoriatic, RA, United States. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
tnf us protein use receptor dna diseases igg1 approved response fusion fc medical european union soluble treat autoimmune immune first
TTTA extracted 115 structured relationships around Etanercept. Examples in this analysis include Etanercept → AHFS/Drugs.com → Monograph and Etanercept → ATC code → L04AB01 (WHO). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Etanercept | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Etanercept | ATC code | L04AB01 (WHO) | 1.00 | infobox |
| Etanercept | Bioavailability | 58–76% (SC) | 1.00 | infobox |
| Etanercept | Biosimilars | etanercept-szzs, etanercept-ykro, Benepali, Brenzys, Erelzi, Etacept, Etera, Eticovo, Fubelv, Lifmior, Nepexto, Rymti | 1.00 | infobox |
| Etanercept | CAS Number | 185243-69-0 | 1.00 | infobox |
| Etanercept | ChEMBL | ChEMBL1201572 | 1.00 | infobox |
| Etanercept | ChemSpider | None | 1.00 | infobox |
| Etanercept | CompTox Dashboard (EPA) | DTXSID8040850 | 1.00 | infobox |
| Etanercept | DrugBank | DB00005 | 1.00 | infobox |
| Etanercept | ECHA InfoCard | 100.224.383 | 1.00 | infobox |
| Etanercept | Elimination half-life | 70–132 hours | 1.00 | infobox |
| Etanercept | Formula | C2224H3475N621O698S36 | 1.00 | infobox |
| Etanercept | KEGG | D00742 | 1.00 | infobox |
| Etanercept | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Etanercept | Legal status | CA: ℞-only / Schedule D | 1.00 | infobox |
| Etanercept | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Etanercept | Legal status | US: ℞-only | 1.00 | infobox |
| Etanercept | Legal status | EU: Rx-only | 1.00 | infobox |
| Etanercept | License data | US DailyMed: Etanercept | 1.00 | infobox |
| Etanercept | MedlinePlus | a602013 | 1.00 | infobox |
| Etanercept | Molar mass | 51235.07 g·mol−1 | 1.00 | infobox |
| Etanercept | Pregnancy category | AU: D | 1.00 | infobox |
| Etanercept | PubChem SID | 7847807 | 1.00 | infobox |
| Etanercept | Routes of administration | Subcutaneous | 1.00 | infobox |
| Etanercept | Trade names | Enbrel | 1.00 | infobox |
| Etanercept | UNII | OP401G7OJC | 1.00 | infobox |
| Etanercept | is a | fusion protein produced by recombinant DNA | 0.90 | text |
| Etanercept | is a | therapeutic alternative on the World Health Organization's List of Essential Medicines | 0.90 | text |
| Etanercept | is a | complex molecule containing 6 N-glycans | 0.90 | text |
The concept neighborhoods around Etanercept bring nearby vocabulary together. In this analysis, examples include Us, Tnf and Use. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Etanercept, one of the stronger structural bridges in this analysis connects Etanercept with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Etanercept to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Etanercept · EN edition · Analysis: TopicsToTalkAbout